Boninsegna S - Search Results

1

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G. Belli LS, et al. Among authors: boninsegna s. Liver Transpl. 2007 May;13(5):733-40. doi: 10.1002/lt.21093. Liver Transpl. 2007. PMID: 17370330 Free article.

2

HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.

Belli LS, Burra P, Poli F, Battista Alberti A, Silini E, Zavaglia C, Fagiuoli S, Prando D, Espadas de Arias A, Boninsegna S, Tinelli C, Scalamogna M, de Carlis L, Pinzello G. Belli LS, et al. Among authors: boninsegna s. Gastroenterology. 2006 Mar;130(3):695-702. doi: 10.1053/j.gastro.2005.11.013. Gastroenterology. 2006. PMID: 16530511

3

HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.

De Martin E, Senzolo M, Boninsegna S, Guido M, Masier A, Germani G, Tomat S, Brolese A, Neri D, Cillo U, Gambato M, Russo FP, Farinati F, Burra P. De Martin E, et al. Among authors: boninsegna s. Transplant Proc. 2008 Jul-Aug;40(6):1974-5. doi: 10.1016/j.transproceed.2008.05.040. Transplant Proc. 2008. PMID: 18675104

4

Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.

Burra P, Targhetta S, Pevere S, Boninsegna S, Guido M, Canova D, Brolese A, Masier A, D'Aloiso C, Germani G, Tomat S, Fagiuoli S. Burra P, et al. Among authors: boninsegna s. Transplant Proc. 2006 May;38(4):1127-30. doi: 10.1016/j.transproceed.2006.02.135. Transplant Proc. 2006. PMID: 16757285

5

Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal.

Floreani A, Boninsegna S, Lobello S, Caroli D, Fagiuoli S. Floreani A, et al. Among authors: boninsegna s. Gastroenterol Clin Biol. 2006 Feb;30(2):307-9. doi: 10.1016/s0399-8320(06)73171-2. Gastroenterol Clin Biol. 2006. PMID: 16565668 Free article.

6

Viral kinetics during the first weeks of pegylated interferon and ribavirin treatment can identify patients at risk of relapse after its discontinuation: new strategies for such patients?

Milan M, Boninsegna S, Scribano L, Lobello S, Fagiuoli S, Fabris P, Buda A, Martines D. Milan M, et al. Among authors: boninsegna s. Infection. 2012 Apr;40(2):173-9. doi: 10.1007/s15010-011-0219-0. Epub 2011 Nov 18. Infection. 2012. PMID: 22095532

7

Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C.

Ferrara F, Ventura P, Vegetti A, Guido M, Abbati G, Corradini E, Fattovich G, Ferrari C, Tagliazucchi M, Carbonieri A, Orlandini A, Fagiuoli S, Boninsegna S, Minola E, Rizzo G, Belussi F, Felder M, Massari M, Pozzato G, Bonetto S, Rovere P, Sardini C, Borghi A, Zeneroli ML, Toniutto P, Rossi E, Pietrangelo A. Ferrara F, et al. Among authors: boninsegna s. Am J Gastroenterol. 2009 Mar;104(3):605-16. doi: 10.1038/ajg.2008.126. Epub 2009 Feb 10. Am J Gastroenterol. 2009. PMID: 19209167

8

Epstein-Barr Virus (EBV) acute acalculous cholecystitis in an immunocompromised adult patient: a case report and a literature review of a neglected clinical presentation.

Boninsegna S, Storato S, Riccardi N, Soprana M, Oliboni E, Tamarozzi F, Bocus P, Martini M, Floreani A. Boninsegna S, et al. J Prev Med Hyg. 2021 Apr 29;62(1):E237-E242. doi: 10.15167/2421-4248/jpmh2021.62.1.1859. eCollection 2021 Mar. J Prev Med Hyg. 2021. PMID: 34322642 Free PMC article. Review.

9

Antiviral activity of bone morphogenetic proteins and activins.

Eddowes LA, Al-Hourani K, Ramamurthy N, Frankish J, Baddock HT, Sandor C, Ryan JD, Fusco DN, Arezes J, Giannoulatou E, Boninsegna S, Chevaliez S, Owens BMJ, Sun CC, Fabris P, Giordani MT, Martines D, Vukicevic S, Crowe J, Lin HY, Rehwinkel J, McHugh PJ, Binder M, Babitt JL, Chung RT, Lawless MW, Armitage AE, Webber C, Klenerman P, Drakesmith H. Eddowes LA, et al. Among authors: boninsegna s. Nat Microbiol. 2019 Feb;4(2):339-351. doi: 10.1038/s41564-018-0301-9. Epub 2018 Dec 3. Nat Microbiol. 2019. PMID: 30510168 Free PMC article.

10

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.

Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M; PegBeLiver Study Group. Lampertico P, et al. Among authors: boninsegna s. Gut. 2013 Feb;62(2):290-8. doi: 10.1136/gutjnl-2011-301430. Epub 2012 Aug 2. Gut. 2013. PMID: 22859496 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page